| Literature DB >> 32770941 |
Xiaoyu Han1,2, Yukun Cao1,2, Zhiguo Ju3, Jia Liu1,2, Na Li1,2, Yumin Li1,2, Tong Liu1,2, Heshui Shi4,5, Jin Gu6,7.
Abstract
BACKGROUND: Computed tomography feature tracking (CT-FT) has emerged as a valuable method for the assessment of cardiac function. However, no studies have investigated the usefulness of CT-derived assessments of left ventricular (LV) strain in coronary artery disease (CAD). Our aim was to evaluate regional LV systolic deformation in patients with left anterior descending coronary artery (LAD) stenosis using CT-FT.Entities:
Keywords: Computed tomography angiography; Coronary artery disease; Strain; Ventricular function
Mesh:
Year: 2020 PMID: 32770941 PMCID: PMC7414558 DOI: 10.1186/s12872-020-01644-5
Source DB: PubMed Journal: BMC Cardiovasc Disord ISSN: 1471-2261 Impact factor: 2.298
Fig. 1The percentage of left anterior descending coronary artery (LAD) stenosis defined by coronary CT angiography. The degrees of LAD stenosis were ≤ 25% (a), 26 to 49% (b), 50 to 74%(c) and ≥ 75% (d)
Fig. 2Diagram of the peak systolic strain analysis of the left ventricular myocardium in a healthy volunteer (a forty-seven-year-old female). Colored tissue-tracking maps of circumferential (a), radial (b), and longitudinal (c, d, e) strain analyses are shown on the left. The circumferential (f), radial (g), and longitudinal (h, i, j) strain values in a 16-segment model are displayed in the middle. Circumferential (l), radial (k), and longitudinal (m, n, o) strain-time curves in a cardiac cycle are shown on the right
Fig. 3The involved segments as the territory supplied by the left anterior descending coronary artery (LAD) based on the American Heart Association (AHA) 16-segment model
Clinical characteristics of the study population
| Variable | Group I | Group II | Group III | Group IV | Control | |
|---|---|---|---|---|---|---|
| Age (years) | 56.7 ± 8 | 54.1 ± 12 | 62 ± 10 | 61 ± 13 | 56.7 ± 11 | 0.255 |
| Male (n, %) | 17 (70.8) | 14 (82.4) | 17 (81) | 11 (78.6) | 19 (57.6) | 0.249 |
| BMI (kg/m2) | 24.9 ± 3 | 25.1 ± 5 | 23.9 ± 4 | 24.8 ± 3 | 24.8 ± 3 | 0.399 |
| Smoking history (Yes/No) | 9/15 | 5/12 | 7/14 | 7/7 | 10/22 | 0.730 |
| Drink history (Yes/No) | 8/16 | 4/13 | 8/13 | 5/9 | 7/25 | 0.707 |
| Heart rate (beats/min) | 70.1 | 71.1 | 69.4 | 71.0 | 69.7 | 0.986 |
| Hypertension (n, %) | 11 (45.8) | 9 (52.9) | 8 (38.1) | 7 (50%) | 0 | 0.204 |
| SBP | 136 ± 20 | 131 ± 18 | 141 ± 20 | 144 ± 23 | 126 ± 16 | 0.013* |
| DBP | 88 ± 16 | 85 ± 15 | 88 ± 15 | 89 ± 12 | 79 ± 16 | 0.091 |
| Diabetes mellitus (n, %) | 4 (16.7) | 1 (5.9) | 5 (23.8) | 2 (14.3) | 0 | 0.386 |
| Medication | ||||||
| ACEIs (Yes/No) | 9/15 | 7/10 | 9/12 | 9/5 | – | – |
| Diuretics (Yes/No) | 5/19 | 4/13 | 8/13 | 7/7 | – | – |
| CCBs (Yes/No) | 8/16 | 6/11 | 10/11 | 10/4 | – | – |
| β-Blockers (Yes/No) | 6/18 | 4/13 | 5/16 | 9/5 | – | – |
| Statins (Yes/No) | 2/22 | 3/14 | 3/19 | 6/8 | – | – |
| Hematocrit (%) | 139.5 | 140.7 | 133 | 138.3 | 132.2 | – |
| Total cholesterol (mmol/L) | 3.61 | 3.94 | 4.91 | 4.99 | 3.92 | – |
| Triglycerides (mmol/L) | 1.72 | 1.76 | 1.55 | 1.64 | 1.56 | – |
| HDL-C (mmol/L) | 1.1 | 1.58 | 2.61 | 0.952 | 1.31 | – |
| LDL-C (mmol/L) | 2.4 | 2.62 | 2.96 | 2.95 | 3.19 | – |
All data are expressed as the mean ± SD, percentage (number of participants), or median (interquartile range), as appropriate
*P < 0.05 between groups
BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, LVH left ventricular hypertrophy, ACEIs angiotensin-converting enzyme inhibitors, ARBs angiotensin II receptor blockers, CCBs channel blockers, HDL-C High density liptein cholesterol, LDL-C low density liptein cholesterol
Cardiac CT parameter of the study population
| Variable | Group I | Group II | Group III | Group IV | Control | |
|---|---|---|---|---|---|---|
| LVEF (%) | 63.3 ± 9 | 63.6 ± 8 | 63.1 ± 9 | 59 ± 13 | 63.9 ± 7 | 0.586 |
| LVEDV (ml) | 90 ± 19 | 84.9 ± 30 | 82.5 ± 19 | 90.1 ± 17 | 87 ± 15 | 0.719 |
| LVESV (ml) | 32.8 ± 10 | 40.6 ± 18 | 30.9 ± 11 | 37.3 ± 17 | 32 ± 10 | 0.257 |
| CS (%) | ||||||
| LAD territory (%) | −24.1 ± 4 | −25.3 ± 6 | −22.4 ± 4*,a | − 22.1 ± 4*,a,b | − 25.4 ± 4 | 0.062 |
| Non- LAD territory (%) | −25.6 ± 5 | −24.4 ± 4 | − 25.9 ± 4 | − 22.9 ± 5 | −27.4 ± 5 | 0.052 |
| GCS (%) | −25 ± 4 | −24.1 ± 4 | − 24.7 ± 6 | −22.4 ± 4 | −26.6 ± 4 | 0.115 |
| RS (%) | ||||||
| LAD territory (%) | 76.6 ± 25 | 79.1 ± 42 | 93.1 ± 56 | 63 ± 23 | 88 ± 38 | 0.186 |
| Non- LAD territory (%) | 90 ± 36 | 96.5 ± 80 | 74.9 ± 23 | 76.4 ± 26 | 84.3 ± 28 | 0.74 |
| GRS (%) | 85.1 ± 26 | 89.1 ± 55 | 81.4 ± 25 | 71.7 ± 23 | 85.3 ± 32 | 0.628 |
| LS (%) | ||||||
| LAD territory (%) | −20.8 ± 3 | −18.6 ± 4*,a | −18.6 ± 3*,a,b | −17 ± 5*,a,b,c | −23.7 ± 3 | <0.001 |
| Non- LAD territory (%) | −22.0 ± 3 | −21.9 ± 3 | −21.9 ± 2 | −20 ± 4 | − 22.0 ± 4 | 0.488 |
| GLS (%) | −20.1 ± 2 | −20.3 ± 3* | − 20.5 ± 3*,a | −18.7 ± 4*,a,b,c | −22.9 ± 3 | <0.001 |
All data are expressed as the mean ± SD, percentage (number of participants), or median (interquartile range), as appropriate
*P < 0.05 compared with normal controls
aP < 0.05 compared with groups I
bP < 0.05 compared with groups II
cP < 0.05 compared with groups III
HR heart rate, LVEF left ventricular ejection fraction. LVEDV left ventricular end-diastolic volume, LVESV left ventricular end-systolic volume, RS radial strain, CS circumferential strain, LS longitudinal strain, GRS global radial strain, GCS global circumferential strain, GLS global longitudinal strain
Peak systolic strain of patients of between the LAD territory and non-LAD territory
| Variable | Strain of LAD territory | Strain of non-LAD territory | |
|---|---|---|---|
| Group I | |||
| CS | −24.1 ± 4 | −25.6 ± 5 | 0.269 |
| RS | 76.6 ± 25 | 90 ± 36 | 0.133 |
| LS | −20.8 ± 3 | − 22.0 ± 3 | 0.085 |
| Group II | |||
| CS | −25.3 ± 6 | −24.4 ± 4 | 0.625 |
| RS | 79.1 ± 42 | 96.5 ± 80 | 0.432 |
| LS | −18.6 ± 4 | −21.9 ± 3 | 0.007* |
| Group III | |||
| CS | −22.4 ± 4 | −25.9 ± 4 | 0.024* |
| RS | 93.1 ± 56 | 74.9 ± 23 | 0.175 |
| LS | −18.6 ± 3 | −20.5 ± 3 | 0.030* |
| Group IV | |||
| CS | −22.1 ± 4 | −22.9 ± 5 | 0.856 |
| RS | 63 ± 23 | 76.4 ± 26 | 0.184 |
| LS | −17 ± 5 | −18.7 ± 4 | 0.032* |
| Control | |||
| CS | −25.4 ± 4 | −27.4 ± 5 | 0.203 |
| RS | 88 ± 38 | 84.3 ± 28 | 0.750 |
| LS | −23.7 ± 3 | −22.9 ± 3 | 0.431 |
All data are expressed as the mean ± SD, percentage (number of participants), or median (interquartile range), as appropriate
*P < 0.05 between groups
LAD left anterior descending, RS radial strain, CS circumferential strain, LS longitudinal strain
Univariate correlation coefficients for RS, CS and LS of LAD territory in patients with LAD stenosis
| CS (%) | RS (%) | LS (%) | ||||
|---|---|---|---|---|---|---|
| Variable | R value | R value | R value | |||
| Age (years) | −0.062 | 0.597 | − 0.013 | 0.912 | − 0.07 | 0.548 |
| Sex | 0.104 | 0.371 | − 0.023 | 0.845 | 0.242 | 0.073 |
| BMI (kg/m2) | 0.088 | 0.448 | 0.027 | 0.816 | 0.061 | 0.604 |
| Hypertension | 0.036 | 0.756 | −0.126 | 0.276 | −0.038 | 0.747 |
| SBP (mmHg) | 0.057 | 0.623 | 0.102 | 0.382 | 0.108 | 0.352 |
| DBP (mmHg) | 0.041 | 0.728 | −0.081 | 0.488 | 0.042 | 0.721 |
| DM | 0.109 | 0.349 | −0.136 | 0.241 | − 0.020 | 0.864 |
| History of smoking | −0.027 | 0.817 | −0.14 | 0.227 | −0.053 | 0.647 |
| History of drinking | −0.035 | 0.764 | −0.06 | 0.606 | −0.108 | 0.351 |
| HR | 0.052 | 0.657 | 0.053 | 0.649 | 0.048 | 0.680 |
| ACEIs (Yes/No) | −0.181 | 0.119 | 0.070 | 0.550 | −0.235 | 0.041* |
| Diuretics (Yes/No) | −0.014 | 0.905 | 0.013 | 0.913 | −0.184 | 0.112 |
| CCBs (Yes/No) | −0.166 | 0.151 | −0.041 | 0.241 | −0.136 | 0.241 |
| β-Blockers (Yes/No) | −0.020 | 0.864 | −0.013 | 0.913 | −0.110 | 0.345 |
| Statins (Yes/No) | 0.076 | 0.513 | −0.011 | 0.922 | −0.091 | 0.435 |
| Hematocrit (%) | 0.307 | 0.093 | −0.067 | 0.736 | −0.024 | 0.903 |
| Total cholesterol (mmol/L) | 0.211 | 0.322 | 0.262 | 0.216 | −0.024 | 0.903 |
| Triglycerides (mmol/L) | 0.009 | 0.969 | 0.180 | 0.423 | 0.069 | 0.749 |
| HDL-C (mmol/L) | 0.115 | 0.610 | 0.219 | 0.328 | −0.551 | 0.008* |
| LDL-C (mmol/L) | 0.365 | 0.086 | −0.125 | 0.579 | −0.203 | 0.365 |
| Degree of stenosis | 0.196 | 0.090 | −0.029 | 0.803 | 0.438 | 0.002* |
| LVEF (%) | −0.323 | 0.005* | 0.115 | 0.324 | −0.315 | 0.009* |
| LVEDV (ml) | 0.092 | 0.427 | −0.304 | 0.008* | 0.083 | 0.474 |
| LVESV (ml) | −0.324 | 0.002* | −0.1 | 0.388 | −0.229 | 0.460 |
Correlation analysis are using Person correlation
*P < 0.05 between groups
BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, LVH left ventricular hypertrophy, ACEIs angiotensin-converting enzyme inhibitors, CCBs channel blockers. HR heart rate, LVEF left ventricular ejection fraction, HDL-C High density liptein cholesterol, LDL-C low density liptein cholesterol, LVEDV left ventricular end-diastolic volume, LVESV left ventricular end-systolic volume, RS radial strain, CS circumferential strain, LS longitudinal strain
Fig. 4Correlations between stenosis of the left anterior descending coronary artery (LAD) and the amplitudes of circumferential strain (a), radial strain (b) longitudinal strain (c) and strain in the LAD territory
Intra- and interobserver reproducibility of CT-FT strain
| Strain | Coefficient ofvariability (%) | ICC(95%CI) |
|---|---|---|
| Interobserver variability | ||
| LAD CS | 7.0 | 0.90 (0.86–0.93) |
| LAD RS | 6.7 | 0.88 (0.79–0.96) |
| LAD LS | 6.5 | 0.86 (0.84–0.89) |
| GCS | 7.8 | 0.96 (0.93–1.00) |
| GRS | 7.4 | 0.94 (0.92–1.00) |
| GLS | 6.6 | 0.87 (0.85–0.93) |
| Intraobserver variability | ||
| LAD CS | 5.9 | 0.89 (0.84–0.94) |
| LAD RS | 6.6 | 0.91 (0.86–0.96) |
| LAD LS | 7.6 | 0.95 (0.90–0.98) |
| GCS | 6.1 | 0.91 (0.88–0.93) |
| GRS | 5.5 | 0.86 (0.83–0.91) |
| GLS | 7.2 | 0.93 (0.90–0.95) |
RS radial strain, CS circumferential strain, LS longitudinal strain, GRS global radial strain, GCS global circumferential strain, GLS global longitudinal strain